Phase 3 Psoriatic Arthritis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 18 years of age or older at the time of signing the consent form (19 or older if in South Korea)
• People who have been diagnosed with psoriatic arthritis (PsA)
• People who have had signs and symptoms of psoriatic arthritis for at least 3 months before the screening visit
• People whose psoriatic arthritis meets a specific set of medical classification standards known as the CASPAR criteria
• People who have active joint disease, shown by at least 3 tender joints and at least 3 swollen joints, confirmed at both the screening and first study visit
• People who have at least one active skin patch of plaque psoriasis that is 2 cm or wider, or who have nail or nail bed changes typical of psoriasis
• People who have previously tried an anti-inflammatory pain medication (such as an NSAID) without enough benefit, OR who have previously tried a standard disease-modifying arthritis medication (csDMARD) without enough benefit (note: the NSAID requirement does not apply in EU/EEA countries)

Who may not be able to join:

• People who have another condition that could make it harder to assess how well the study treatment is working — for example, rheumatoid arthritis, lupus, Lyme disease, gout, fibromyalgia, or a related joint condition called axial spondyloarthritis
• People who have a skin condition alongside their psoriasis that, in the study doctor's opinion, could interfere with skin assessments — for example, certain other forms of psoriasis such as pustular, erythrodermic, guttate, inverse, or drug-induced psoriasis

Important: Always verify eligibility with the trial site directly before applying.